DK321180A - Fremgangsmaade til fremstilling af 9alfa,11betadichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion - Google Patents

Fremgangsmaade til fremstilling af 9alfa,11betadichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion

Info

Publication number
DK321180A
DK321180A DK321180A DK321180A DK321180A DK 321180 A DK321180 A DK 321180A DK 321180 A DK321180 A DK 321180A DK 321180 A DK321180 A DK 321180A DK 321180 A DK321180 A DK 321180A
Authority
DK
Denmark
Prior art keywords
oxycarbonyldicyclohexylmethyloxypregna
9alfa
16alfa
dion
dien
Prior art date
Application number
DK321180A
Other languages
English (en)
Other versions
DK146690C (da
DK146690B (da
Inventor
R Deraedt
J G Teutsch
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK321180A publication Critical patent/DK321180A/da
Publication of DK146690B publication Critical patent/DK146690B/da
Application granted granted Critical
Publication of DK146690C publication Critical patent/DK146690C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK321180A 1979-07-26 1980-07-25 Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion DK146690C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7919296 1979-07-26
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Publications (3)

Publication Number Publication Date
DK321180A true DK321180A (da) 1981-01-27
DK146690B DK146690B (da) 1983-12-05
DK146690C DK146690C (da) 1984-05-21

Family

ID=9228325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321180A DK146690C (da) 1979-07-26 1980-07-25 Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion

Country Status (20)

Country Link
US (1) US4353899A (da)
JP (1) JPS5622798A (da)
AT (1) AT371483B (da)
AU (1) AU528292B2 (da)
BE (1) BE884494A (da)
CA (1) CA1141751A (da)
CH (1) CH645389A5 (da)
DE (1) DE3028255C2 (da)
DK (1) DK146690C (da)
FI (1) FI66880C (da)
FR (1) FR2462443A1 (da)
GB (1) GB2054600B (da)
HU (1) HU180364B (da)
IE (1) IE50031B1 (da)
IT (1) IT1145302B (da)
MX (1) MX6649E (da)
NL (1) NL8004282A (da)
NO (1) NO153102C (da)
SE (1) SE447387B (da)
ZA (1) ZA803867B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
DE19932511A1 (de) * 1999-07-12 2001-01-18 Helmig Hans Gmbh Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122815C (da) * 1963-12-19
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane

Also Published As

Publication number Publication date
NO153102B (no) 1985-10-07
FR2462443B1 (da) 1982-12-31
HU180364B (en) 1983-02-28
JPS5622798A (en) 1981-03-03
IT8049248A0 (it) 1980-07-15
FI802092A (fi) 1981-01-27
DK146690C (da) 1984-05-21
IT1145302B (it) 1986-11-05
SE8004428L (sv) 1981-01-27
IE801561L (en) 1981-01-26
SE447387B (sv) 1986-11-10
IE50031B1 (en) 1986-02-05
GB2054600B (en) 1983-02-02
NL8004282A (nl) 1981-01-28
CH645389A5 (fr) 1984-09-28
NO153102C (no) 1986-01-15
US4353899A (en) 1982-10-12
GB2054600A (en) 1981-02-18
CA1141751A (fr) 1983-02-22
BE884494A (fr) 1981-01-26
AU6081180A (en) 1981-01-29
ATA391380A (de) 1982-11-15
FR2462443A1 (fr) 1981-02-13
FI66880B (fi) 1984-08-31
DE3028255A1 (de) 1981-02-19
NO802256L (no) 1981-01-27
ZA803867B (en) 1981-06-24
DK146690B (da) 1983-12-05
DE3028255C2 (de) 1985-12-19
JPS6254438B2 (da) 1987-11-14
MX6649E (es) 1985-10-01
AU528292B2 (en) 1983-04-21
AT371483B (de) 1983-06-27
FI66880C (fi) 1984-12-10

Similar Documents

Publication Publication Date Title
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK540080A (da) Fremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
DK268879A (da) Fremgangsmaade til fremstilling af octahydropyrazolo (3,4-g)-quinoliner
DK89783A (da) Fremgangsmaade til fremstilling af 3-keto-delta4,9-19-nor-steroidderivater
DK364579A (da) Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK143401C (da) Fremgangsmaade til fremstilling af 3-substituerede 6a,10a-trans-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo-(b,d)pyran-9-oner
DK143491D0 (da) Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion
DK210083D0 (da) Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK447380A (da) Fremgangsmaade til fremstilling af d3-vitaminforbindelser
DK142080C (da) Fremgangsmaade til fremstilling af 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-oner
DK165687C (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK150479C (da) Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK62880A (da) Fremgangsmaade til fremstilling af mchlorsubstituerede aniliner
DK454579A (da) Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK158837C (da) Fremgangsmaade til fremstilling af p-hydroxyphenylglycin.
DK308180A (da) Fremgangsmaade til fremstilling af 2,3-dihydro2,2-dimethyl-7-hydroxybenzofuran
DK174380A (da) Fremgangsmaade til fremstilling af 2!,6!adialkyl-n-alkoxymethyl-2-chlor-acetanillider
DK321180A (da) Fremgangsmaade til fremstilling af 9alfa,11betadichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
DK217480A (da) Fremgangsmaade til fremstilling af 5-mercapto1,2,3-triazoler
DK144885C (da) Fremgangsmaade til fremstilling af 3-substituerede cis-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)-pyran-9-oner
DK375480A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-3-thioler
DK149962C (da) Fremgangsmaade til fremstilling af 2,5-diketogluconsyre
DK393079A (da) Fremgangsmaade til fremstilling af n,n-dimethylaminoacetonitril
DK287480A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin